Advantages and limitations of microarray technology in human cancer

被引:192
作者
Russo, G
Zegar, C
Giordano, A
机构
[1] Temple Univ, Dept Biotechnol, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA
[2] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy
基金
美国国家卫生研究院;
关键词
microarray; proteomics; human cancer;
D O I
10.1038/sj.onc.1206865
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is a highly variable disease with multiple heterogeneous genetic and epigenetic changes. Functional studies are essential to understanding the complexity and polymorphisms of cancer. The final deciphering of the complete human genome, together with the improvement of high throughput technologies, is causing a fundamental transformation in cancer research. Microarray is a new powerful tool for studying the molecular basis of interactions on a scale that is impossible using conventional analysis. This technique makes it possible to examine the expression of thousands of genes simultaneously. This technology promises to lead to improvements in developing rational approaches to therapy as well as to improvements in cancer diagnosis and prognosis, assuring its entry into clinical practice in specialist centers and hospitals within the next few years. Predicting who will develop cancer and how this disease will behave and respond to therapy after diagnosis will be one of the potential benefits of this technology within the next decade. In this review, we highlight some of the recent developments and results in microarray technology in cancer research, discuss potentially problematic areas associated with it, describe the eventual use of microarray technology for clinical applications and comment on future trends and issues.
引用
收藏
页码:6497 / 6507
页数:11
相关论文
共 131 条
[1]  
Agrawal D, 2002, J NATL CANCER I, V94, P513
[2]   Identification of high risk breast-cancer patients by gene expression profiling [J].
Ahr, A ;
Karn, T ;
Solbach, C ;
Seiter, T ;
Strebhardt, K ;
Holtrich, U ;
Kaufmann, M .
LANCET, 2002, 359 (9301) :131-132
[3]   Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells [J].
Al Moustafa, AE ;
Alaoui-Jamali, MA ;
Batist, G ;
Hernandez-Perez, M ;
Serruya, C ;
Alpert, L ;
Black, MJ ;
Sladek, R ;
Foulkes, WD .
ONCOGENE, 2002, 21 (17) :2634-2640
[4]   Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis [J].
Alevizos, I ;
Mahadevappa, M ;
Zhang, X ;
Ohyama, H ;
Kohno, Y ;
Posner, M ;
Gallagher, GT ;
Varvares, M ;
Cohen, D ;
Kim, D ;
Kent, R ;
Donoff, RB ;
Todd, R ;
Yung, CM ;
Warrington, JA ;
Wong, DTW .
ONCOGENE, 2001, 20 (43) :6196-6204
[5]   The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes [J].
Alizadeh, A ;
Eisen, M ;
Davis, RE ;
Ma, C ;
Sabet, H ;
Tran, T ;
Powell, JI ;
Yang, L ;
Marti, GE ;
Moore, DT ;
Hudson, JR ;
Chan, WC ;
Greiner, T ;
Weisenburger, D ;
Armitage, JO ;
Lossos, I ;
Levy, R ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 :71-78
[6]   Towards a novel classification of human malignancies based on gene expression patterns [J].
Alizadeh, AA ;
Ross, DT ;
Perou, CM ;
van de Rijn, M .
JOURNAL OF PATHOLOGY, 2001, 195 (01) :41-52
[7]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[8]  
Backert S, 1999, INT J CANCER, V82, P868, DOI 10.1002/(SICI)1097-0215(19990909)82:6<868::AID-IJC16>3.0.CO
[9]  
2-W
[10]  
Bärlund M, 2000, CANCER RES, V60, P5340